Fundraising Fox

SpineThera

Plymouth, US · Founded 2011 · Delaware corporation

Biotech

Founders & leadership

JM
Jeff MisslingExecutive

Board

JJ
Jerome JeromeBoard director
WK
Wayne KellyBoard director

Reported raises · per SEC filings

Form D private placements

$11.5M disclosed across 7 rounds · 2014–2021

▶$1.2MraisedDec 2021 · 12 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Wayne KellyDirector
  • Jerome JeromeDirector
  • Jeffrey MisslingExecutive Officer, Director
  • John FosterDirector
Offering amount
$4M
Amount sold
$1.2M
First sale
Jun 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedNov 2018 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jerome JeromeDirector
  • John FosterDirector
  • Wayne KellyDirector
  • Jeffrey MisslingExecutive Officer, Director
  • John RengerDirector
Offering amount
$2M
Amount sold
$2M
Minimum investment
$2M
Sales commissions
$140K
Placement agents
LAKE STREET CAPITAL MARKETS, LLC
First sale
Nov 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedAug 2018 · 25 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • David WoodDirector
  • Jerome K. JeromeDirector
  • Jeffrey MisslingExecutive Officer, Director
  • John FosterDirector
  • Wayne KellyDirector
Offering amount
$5M
Amount sold
$3M
Minimum investment
$25K
First sale
Feb 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedFeb 2018 · 14 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jerome K. JeromeDirector
  • David WoodDirector
  • Jeffrey MisslingExecutive Officer, Director
  • John FosterDirector
  • Wayne KellyDirector
Offering amount
$5M
Amount sold
$2M
Minimum investment
$25K
First sale
Feb 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$400KraisedSep 2015 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeff MisslingExecutive Officer, Director
  • Wayne KellyDirector
  • Jerome JeromeDirector
Offering amount
$400K
Amount sold
$400K
First sale
Aug 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.4MraisedAug 2015 · 17 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jerome JeromeDirector
  • Jeff MisslingExecutive Officer, Director
  • Wayne KellyDirector
Offering amount
$3.3M
Amount sold
$2.4M
Proceeds to insiders
$200K
First sale
Jul 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$585.1KraisedMay 2014 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeff MisslingExecutive Officer, Director
  • Jerome JeromeDirector
Offering amount
$2M
Amount sold
$585.1K
Proceeds to insiders
$150K
First sale
May 2014
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

SpineThera Awarded $5 Million Grant from Department of Defensebusinesswire.com · Apr 2022Maker of OxyContin strikes deal for SpineThera - StarTribune.comstartribune.com · Oct 2018SpineThera Raises $2M as it Readies for Clinical Trials | Twin Cities Businesstcbmag.com · Feb 2018CVRx – Medical Alley Associationmedicalalley.org

Frequently asked questions

How much funding has SpineThera raised?
SpineThera has disclosed $11.5M raised across 7 rounds.
Where is SpineThera headquartered?
SpineThera is headquartered in Plymouth, US.